63 related articles for article (PubMed ID: 38521834)
1. The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis.
Freier A; Lawson McLean AC; Loeschner D; Rosahl SK; Kruse J
Sci Rep; 2024 Mar; 14(1):6934. PubMed ID: 38521834
[TBL] [Abstract][Full Text] [Related]
2. Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.
Wolters PL; Ghriwati NA; Baker M; Martin S; Berg D; Erickson G; Franklin B; Merker VL; Oberlander B; Reeve S; Rohl C; Rosser T; Vranceanu AM
Clin Trials; 2024 Feb; 21(1):73-84. PubMed ID: 37962219
[TBL] [Abstract][Full Text] [Related]
3. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
Merker VL; Bredella MA; Cai W; Kassarjian A; Harris GJ; Muzikansky A; Nguyen R; Mautner VF; Plotkin SR
Am J Med Genet A; 2014 Jun; 164A(6):1431-7. PubMed ID: 24664633
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.
Blakeley JO; Plotkin SR
Neuro Oncol; 2016 May; 18(5):624-38. PubMed ID: 26851632
[TBL] [Abstract][Full Text] [Related]
5. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Plotkin SR; Messiaen L; Legius E; Pancza P; Avery RA; Blakeley JO; Babovic-Vuksanovic D; Ferner R; Fisher MJ; Friedman JM; Giovannini M; Gutmann DH; Hanemann CO; Kalamarides M; Kehrer-Sawatzki H; Korf BR; Mautner VF; MacCollin M; Papi L; Rauen KA; Riccardi V; Schorry E; Smith MJ; Stemmer-Rachamimov A; Stevenson DA; Ullrich NJ; Viskochil D; Wimmer K; Yohay K; ; Huson SM; Wolkenstein P; Evans DG
Genet Med; 2022 Sep; 24(9):1967-1977. PubMed ID: 35674741
[TBL] [Abstract][Full Text] [Related]
6. Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
Ahlawat S; Blakeley JO; Langmead S; Belzberg AJ; Fayad LM
Skeletal Radiol; 2020 Feb; 49(2):199-219. PubMed ID: 31396668
[TBL] [Abstract][Full Text] [Related]
7. The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity.
Lawson McLean AC; Freier A; Lawson McLean A; Kruse J; Rosahl S
Orphanet J Rare Dis; 2023 Jan; 18(1):3. PubMed ID: 36604703
[TBL] [Abstract][Full Text] [Related]
8. Healthcare access, satisfaction, and health-related quality of life among children and adults with rare diseases.
Bogart K; Hemmesch A; Barnes E; Blissenbach T; Beisang A; Engel P;
Orphanet J Rare Dis; 2022 May; 17(1):196. PubMed ID: 35549731
[TBL] [Abstract][Full Text] [Related]
9. Perceived burden in dealing with different rare diseases: a qualitative focus group study.
Uhlenbusch N; Löwe B; Depping MK
BMJ Open; 2019 Dec; 9(12):e033353. PubMed ID: 31888936
[TBL] [Abstract][Full Text] [Related]
10. Association between patient-reported outcomes and objective disease indices in people with NF2.
Shukla A; Hsu FC; Slobogean B; Langmead S; Lu Y; Blakeley JO; Strowd RE
Neurol Clin Pract; 2019 Aug; 9(4):322-329. PubMed ID: 31583187
[TBL] [Abstract][Full Text] [Related]
11. Screening and intervening: Psychological distress in neurofibromatosis type 2 (NF2).
Quarmby LM; Dalton LJ; Woolrich RA; Clarke R; Emmanouil B; Patel S; Rands G; Parry A; Halliday D
Psychooncology; 2019 Jul; 28(7):1583-1587. PubMed ID: 31033096
[No Abstract] [Full Text] [Related]
12. Depression and anxiety in patients with different rare chronic diseases: A cross-sectional study.
Uhlenbusch N; Löwe B; Härter M; Schramm C; Weiler-Normann C; Depping MK
PLoS One; 2019; 14(2):e0211343. PubMed ID: 30785907
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of Factor Structure and Construct Validity of the 12-Item Short Version of the OPD Structure Questionnaire (OPD-SQS) in Psychosomatic Patients].
Obbarius A; Obbarius N; Fischer F; Liegl G; Rose M
Psychother Psychosom Med Psychol; 2019 Jan; 69(1):38-48. PubMed ID: 29448281
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
